Natural history and management of Kommerell's diverticulum in a single tertiary referral center.


Journal

Journal of vascular surgery
ISSN: 1097-6809
Titre abrégé: J Vasc Surg
Pays: United States
ID NLM: 8407742

Informations de publication

Date de publication:
06 2020
Historique:
received: 11 02 2019
accepted: 18 08 2019
pubmed: 12 11 2019
medline: 3 11 2020
entrez: 12 11 2019
Statut: ppublish

Résumé

The Kommerell diverticulum (KD) is an extremely rare developmental abnormality of the aorta related to an aberrant subclavian artery (ASCA). The objective of our study was to review the natural history of KD and ASCA using our single-center experience in diagnosing and managing KD and ASCA. A retrospective review of the Yale radiological database from January 1999 to December 2016 was performed. Only patients with KD/ASCA and a computed tomography (CT) scan of the chest were selected for review. The primary goal was to examine the natural history of KD and ASCA and the secondary goals were to review the management and outcomes of those patients treated for KD and ASCA. There were 75 patients with KD/ASCA identified, with a mean age of 63 ± 19 years; 49 were female (65%). On CT scans, left- and right-sided aortas were present in 47 (63%) and 28 (37%) patients. A right ASCA or a left ASCA were present in 47 (63%) and 28 (37%) patients. Six patients were symptomatic on presentation. Symptoms included dysphagia, chest or back pain, and emboli to the fingers. The mean KD diameter was 21.8 ± 6.0 mm and the distance to the opposite aortic wall (DAW) was 48.3 ± 10.8 mm. Sixty-six patients were followed for a mean of 31.7 ± 32.5 months. One patient ruptured without repair. Nine patients underwent operative intervention, including eight open and one endovascular repair. Complications from operative intervention included ischemic stroke with hemorrhagic transformation, deep vein thrombosis and pneumonia. The mean growth rate for KD and DAW was 1.45 ± 0.39 mm/year and 2.29 ± 0.47 mm/year, respectively. On multivariable regression analysis, hypertension was a predictor of growth of DAW (P = .03). KD is uncommon and shows a female predominance. The diverticulum grows, albeit slowly (KD and DAW growth rates of 1.45 ± 0.39 mm/year and 2.29 ± 0.47 mm/year). Most patients are asymptomatic, but dysphagia, chest/back pain, and distal emboli may occur. Rupture is rare. Symptomatic patients should be operated. Asymptomatic patients can be followed with serial CT scans.

Identifiants

pubmed: 31708305
pii: S0741-5214(19)32336-5
doi: 10.1016/j.jvs.2019.08.260
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2004-2011

Informations de copyright

Copyright © 2019 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Auteurs

Young Erben (Y)

Division of Vascular and Endovascular Surgery, Mayo Clinic, Jacksonville, Fla.

Adam J Brownstein (AJ)

Aortic Institute at Yale-New Haven Hospital, Yale School of Medicine, New Haven, Conn.

Camilo A Velasquez (CA)

Aortic Institute at Yale-New Haven Hospital, Yale School of Medicine, New Haven, Conn.

Yupeng Li (Y)

Department of Political Science and Economics, Rowan University, Glassboro, NJ.

John A Rizzo (JA)

Aortic Institute at Yale-New Haven Hospital, Yale School of Medicine, New Haven, Conn.

Hamid Mojibian (H)

Section of Vascular Interventional Radiology, Yale School of Medicine, New Haven, Conn.

Maryam Tanweer (M)

Aortic Institute at Yale-New Haven Hospital, Yale School of Medicine, New Haven, Conn.

Mohammad A Zafar (MA)

Aortic Institute at Yale-New Haven Hospital, Yale School of Medicine, New Haven, Conn.

Bulat A Ziganshin (BA)

Aortic Institute at Yale-New Haven Hospital, Yale School of Medicine, New Haven, Conn.

John A Elefteriades (JA)

Aortic Institute at Yale-New Haven Hospital, Yale School of Medicine, New Haven, Conn. Electronic address: john.elefteriades@yale.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH